Bevin Newman is a nationally recognized antitrust lawyer who guides clients through complex merger reviews, government investigations and strategic collaborations. For more than three decades, Bevin has served as a trusted advisor to some of the most significant health care and life sciences companies in the country through innovative and complex transactions and has advised U.S. and international clients on high-profile transactions across the technology, retail, mining and energy industries.
Bevin regularly represents companies before the Federal Trade Commission, the Department of Justice and state attorneys general and other state authorities in merger and acquisitions, as well as civil conduct matters. Known as one of the most experienced Hart-Scott-Rodino (HSR) Act practitioners in the country, Bevin also leads multijurisdictional merger control and foreign direct investment reviews, including before the Committee on Foreign Investment in the United States (CFIUS).
In addition to her antitrust work, Bevin maintains an active pro bono practice advocating for equal rights for the LGBTQ+ community and those living with HIV/AIDS and representing refugees seeking asylum and safety for their families.
Education
- Columbia Law School (J.D., 1995)
- Harlan Fiske Stone Scholar
- Massachusetts Institute of Technology (B.S., 1992)
- National Merit Scholar
Bar Admission
- District of Columbia
Professional Affiliations
- American Health Law Association
- American Bar Association
- Lambda Legal National Leadership Council
Recognition
- Recognized as an M&A Client Service All Star, BTI Consulting, 2021
- Named a Recommended Lawyer, Antitrust – Merger Control, Legal 500, 2021-2023, 2025
